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ABSTRACT Dynamin-like guanylate binding proteins (GBPs) are gamma interferon
(IFN-)-inducible host defense proteins that can associate with cytosol-invading bac-
terial pathogens. Mouse GBPs promote the lytic destruction of targeted bacteria in
the host cell cytosol, but the antimicrobial function of human GBPs and the mecha-
nism by which these proteins associate with cytosolic bacteria are poorly under-
stood. Here, we demonstrate that human GBP1 is unique among the seven human
GBP paralogs in its ability to associate with at least two cytosolic Gram-negative bacte-
ria, Burkholderia thailandensis and Shigella ﬂexneri. Rough lipopolysaccharide (LPS) mu-
tants of S. ﬂexneri colocalize with GBP1 less frequently than wild-type S. ﬂexneri does,
suggesting that host recognition of O antigen promotes GBP1 targeting to Gram-
negative bacteria. The targeting of GBP1 to cytosolic bacteria, via a unique triple-
arginine motif present in its C terminus, promotes the corecruitment of four addi-
tional GBP paralogs (GBP2, GBP3, GBP4, and GBP6). GBP1-decorated Shigella organisms
replicate but fail to form actin tails, leading to their intracellular aggregation. Conse-
quentially, the wild type but not the triple-arginine GBP1 mutant restricts S. ﬂexneri
cell-to-cell spread. Furthermore, human-adapted S. ﬂexneri, through the action of
one its secreted effectors, IpaH9.8, is more resistant to GBP1 targeting than the non-
human-adapted bacillus B. thailandensis. These studies reveal that human GBP1
uniquely functions as an intracellular “glue trap,” inhibiting the cytosolic movement
of normally actin-propelled Gram-negative bacteria. In response to this powerful hu-
man defense program, S. ﬂexneri has evolved an effective counterdefense to restrict
GBP1 recruitment.
IMPORTANCE Several pathogenic bacterial species evolved to invade, reside in, and
replicate inside the cytosol of their host cells. One adaptation common to most cy-
tosolic bacterial pathogens is the ability to coopt the host’s actin polymerization ma-
chinery in order to generate force for intracellular movement. This actin-based motil-
ity enables Gram-negative bacteria, such as Shigella species, to propel themselves
into neighboring cells, thereby spreading from host cell to host cell without exiting
the intracellular environment. Here, we show that the human protein GBP1 acts as a
cytosolic “glue trap,” capturing cytosolic Gram-negative bacteria through a unique
protein motif and preventing disseminated infections in cell culture models. To es-
cape from this GBP1-mediated host defense, Shigella employs a virulence factor that
prevents or dislodges the association of GBP1 with cytosolic bacteria. Thus, thera-
peutic strategies to restore GBP1 binding to Shigella may lead to novel treatment
options for shigellosis in the future.
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Cell-autonomous immunity describes the ability of a single cell to defend itselfagainst intracellular pathogens and constitutes an essential branch of the immune
system (1, 2). Cell-autonomous immunity in vertebrates is often orchestrated by
interferon (IFN)-stimulated genes (ISGs) (2). Among the most robustly expressed ISGs
are those encoding dynamin-like guanylate binding proteins (GBPs) (3–5). GBPs control
intrinsic antiviral, antiprotozoan, and antibacterial immunity, are highly expressed in
inﬂamed tissue, and can be predictive of infectious disease progressions (5–10). Since
their discovery, seven human GBP orthologs and one pseudogene have been identiﬁed.
The GBP genes are located within one gene cluster on chromosome 1 (11). Other
vertebrate genomes contain comparable numbers of GBP orthologs; e.g., mice possess
11 genes in addition to 2 pseudogenes (12). Human and mouse GBPs share a high
degree of homology, with the most conserved region found within their N-terminal G
domains. However, GBP protein family members are highly divergent from each other
at their very C-terminal ends, both within and across different vertebrate species (11).
The functional consequence of this C-terminal amino acid sequence variability has not
been previously explored.
To exert many of their antimicrobial functions, GBPs speciﬁcally associate with
intracellular microbes residing in the host cell cytosol or at pathogen-occupied supra-
molecular structures, which include viral replication complexes (10) and pathogen-
containing vacuoles (3–5). Following pathogen recognition, GBPs are thought to deliver
antimicrobial host factors to pathogen-containing vacuoles and to bacteria residing in
the host cell cytosol, thereby enabling the execution of distinct defense pathways
which include membranolytic destruction of cytosolic bacteria (13, 14), capture of
microbes within degradative autolysosomes (7), and activation of inﬂammasomes
(13–19). These studies clearly demonstrated the importance of GBPs in host defense
against a broad spectrum of pathogens in a vertebrate host. However, because these
previous studies were conducted almost exclusively with mouse models, it remains to
be determined whether human GBPs execute functions comparable to those of their
murine counterparts.
In this study, we systematically tested all seven members of the human GBP protein
family for their ability to colocalize with the cytosolic bacterial pathogens Listeria
monocytogenes, Shigella ﬂexneri, and Burkholderia thailandensis. All of these bacterial
species are equipped with the ability to coopt the host actin polymerization machinery
for actin-based cytosolic motility and cell-to-cell spread (20). While we failed to detect
any colocalization between human GBPs and the Gram-positive bacterium L. monocy-
togenes, we found that GBP1, independently of other human GBP paralogs, targeted
both of the Gram-negative bacteria B. thailandensis and S. ﬂexneri. This speciﬁc inter-
action between GBP1 and bacteria, which is determined by a unique C-terminal
triple-arginine motif, inhibits actin tail formation of GBP1-decorated bacteria, resulting
in a reduction of bacterial cell-to-cell spread. We further observed that GBP1 targeted
the non-human-adapted microbe B. thailandensis more efﬁciently than the human-
adapted pathogen S. ﬂexneri, leading us to hypothesize that S. ﬂexneri actively inter-
ferers with GBP1 function. In agreement with this hypothesis and conﬁrming similar
results published during the preparation of this paper (21, 22), we identiﬁed the
bacterial ubiquitin E3 ligase IpaH9.8 as an S. ﬂexneri virulence factor that interferes with
GBP1 recruitment to this professional cytosolic bacterium. Thus, this study provides a
novel understanding of the role of human GBPs in immunity to bacterial pathogens and
also deﬁnes a virulence strategy employed by a human-adapted microbe to escape
from GBP1-regulated host defense.
RESULTS
Human GBP1 colocalizes with cytosolic S. ﬂexneri and B. thailandensis. Most
known GBP-mediated antimicrobial functions require that GBPs directly localize to
intracellular microbes or their surrounding vacuoles (3–5). Based on this premise, we
screened the entire set of human GBPs (GBP1 to -7) as ectopically expressed mCherry
N-terminal fusion proteins in the human epithelial lung carcinoma cell line A549 for
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colocalization with the cytosolic bacterial pathogen S. ﬂexneri. Expression of each fusion
protein was detectable by Western blotting (Fig. S1) and by immunoﬂuorescence assay
(Fig. 1A). Unexpectedly, only a single member, GBP1, associated with cytosolic S. ﬂex-
neri, as assessed at 1 and 3 h postinfection (hpi) in either naive or gamma interferon
(IFN-)-primed A549 cells (Fig. 1A). Association of GBP1 with individual S. ﬂexneri
bacteria was observed as early as 10 min after host cell invasion (data not shown and
Movie S1 in the supplemental material). Similarly, we observed that GBP1 was the sole
human GBP family member to colocalize with the cytosolic Gram-negative bacterium
B. thailandensis in either naive or IFN--primed A549 cells (Fig. 1B). Unlike with the
observed targeting of GBP1 to these Gram-negative bacteria, we failed to detect any
colocalization of any human GBP paralog with L. monocytogenes, a cytosolic Gram-
positive pathogen (Fig. 1C).
Targeting of GBP1 to S. ﬂexneri is dependent on its functional G domain, CaaX
box, and C-terminal triple-arginine motif. To determine which protein motifs and
properties of GBP1 (Fig. 2A) render it uniquely capable of detecting cytosolic Gram-
negative bacteria, we generated and screened a large set of GBP1 mutant variants for
colocalization with cytosolic S. ﬂexneri. Mutant variants previously established as being
FIG 1 Ectopically expressed human GBP1 colocalizes with Gram-negative S. ﬂexneri and B. thailandensis but not Gram-positive
L. monocytogenes in human A549 cells. A549 cells were transfected with the indicated GBP paralogs fused to mCherry at their N termini
or transfected with the mCherry control. Cells were primed with IFN- at 200 U/ml overnight or left untreated. (A) Cells were infected
with GFP-positive S. ﬂexneri at a multiplicity of infection (MOI) of 50, and microscopy images were taken at 1 and 3 hpi (1-hpi images
are shown). (B) Cells were infected with GFP-positive B. thailandensis at an MOI of 100, and images were acquired at 8 hpi. (C) Cells
were infected with GFP-positive L. monocytogenes at an MOI of 5 and monitored at 1 hpi and 3 hpi (1-hpi image and 1-h data are
shown). (A to C) Combined data from 3 independent experiments are shown. Per experiment, 200 bacteria were scored in
transfected, i.e., mCherry-positive, cells. Error bars indicate SEM. Signiﬁcance was determined by two-way ANOVA. ***, P  0.001; ****,
P  0.0001; n.s., nonsigniﬁcant; n.d., not detectable.
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defective for GTP hydrolysis (GBP1R48A) or nucleotide binding (GBP1K51A and GBP1S52N)
(23, 24) failed to associate with S. ﬂexneri (Fig. 2B). These ﬁndings were expected,
because GTP binding and hydrolysis are required for GBP1 dimerization, protein
polymerization, and membrane binding (23–28). We also found that targeting to
S. ﬂexneri was dependent on the C-terminal CaaX box of GBP1 (Fig. 2B). This ﬁnding was
also expected, as CaaX box-dependent prenylation of GBP1 provides a lipid anchor
critical for the membrane association of GBP1 (27–29).
Both GBP1 and GBP2 contain highly homologous N-terminal G domains and carry
C-terminal CaaX boxes (11), yet only GBP1 efﬁciently associates with S. ﬂexneri in A549
cells (Fig. 1A). We therefore generated protein chimeras between GBP1 and GBP2 to
map the motif that uniquely directs GBP1 to cytosolic bacteria. Most of the divergence
between GBP1 and GBP2 sequences is found within the C-terminal subdomain (CTSD)
consisting of -helices 12 and 13, a short ﬂexible region, and the CaaX box. We
therefore swapped the CTSDs of GBP1 and GBP2 to generate two complementary
chimeric proteins and found that the GBP1- but not the GBP2-derived CTSD determined
protein targeting to S. ﬂexneri (Fig. 2C). Swapping the CaaX boxes on the other hand
FIG 2 Targeting of GBP1 to S. ﬂexneri is dependent on its functional G domain, its CaaX box, and a
C-terminal triple-arginine motif. (A) Schematic depiction of critical protein motifs, domains, and speciﬁc
residues within the structure of human GBP1. (B) A549 cells were transfected with the mCherry construct
(Control), mCherry-tagged wild-type GBP1, and mCherry-tagged GBP1 variants defective in GTP hydro-
lysis (R48A), nucleotide binding (K51A and S52N), or farnesylation (Δ589–592 and C589A), as indicated.
Cells were infected with GFP S. ﬂexneri at an MOI of 50 and assessed for colocalization with mCherry
at 3 hpi inside mCherry-expressing cells. (C and D) HEK 293T cells were transfected with the mCherry
construct (Control), mCherry-tagged wild-type constructs (GBP1 and GBP2), and chimeric (GBP1/2CTSD,
GBP1/2CaaX, GBP2/1CTSD, GBP2/1CaaX), deletion mutant (GBP1ΔPBM), triple mutant (R584–586A), or inser-
tion mutant (GBP2PBM, GBP2PBMGBP1-CaaX) constructs. Cells were infected with GFP S. ﬂexneri at an
MOI of 50 and assessed for colocalization with mCherry at 3 hpi inside mCherry-expressing cells. CTSD,
C-terminal subdomain; PBM, polybasic protein motif. Combined data from 3 independent experiments
are shown. Per experiment, 200 bacteria were scored. Error bars indicate SEM. Signiﬁcance was
determined by one-way ANOVA relative to results for GBP1 (B) or as indicated (C and D). *, P  0.05; ***,
P  0.001; ****, P  0.0001; n.s., nonsigniﬁcant.
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only moderately reduced GBP1 targeting to bacteria (Fig. 2C), indicating the existence
of an additional motif within the GBP1 CTSD critical for bacterial recognition. Within the
ﬂexible region of CTSD, we identiﬁed a GBP1-speciﬁc polybasic protein motif (PBM), a
6-amino-acid stretch containing 5 basic residues (KMRRRK). Deletion of these 6 residues
or mutation of the triple-arginine cassette to triple alanine abrogated colocalization of
GBP1 with S. ﬂexneri (Fig. 2C). In a complementary approach, we found that insertion
of the GBP1 PBM between GBP2 residues 586 and 587 (GBP2PBM) was sufﬁcient to
drive signiﬁcant targeting of GBP2 to S. ﬂexneri (Fig. 2C). Swapping the GBP2 CaaX box
with that of GBP1 (GBP2PBMGBP1-CaaX) further improved the bacterium-targeting
efﬁciency such that GBP2PBMGBP1-CaaX is recruited to Shigella at levels comparable to
those of wild-type GBP1 (Fig. 2D). These data demonstrate that the C-terminal PBM of
GBP1 is essential and sufﬁcient to equip both GBP1 and GBP2 with the ability to detect
cytosolic S. ﬂexneri and that the GBP1 CaaX box further improves targeting efﬁciency.
Triple-arginine motif controls delivery of GBP1 to sterilely damaged vacuoles.
To identify possible molecular targets for the C-terminal PBM of GBP1, we followed up
on our previous published observation that GBP1, but none of its human paralogs,
detects sterilely damaged endogenous vacuoles in human embryonic kidney 293T (HEK
293T) cells (30). The disruption of vacuoles leads to the cytosolic exposure of glycans
that are normally conﬁned to the vacuolar lumen. These exposed sugars then prompt
the recruitment of the -galactoside-binding lectin galectin-3 as an established marker
for loss of vacuolar integrity (31). To determine whether the PBM of GBP1 could
promote the recognition of glycans, we tested its role in the delivery of GBP1 to
ruptured vesicles. We ﬁrst determined whether the structural requirements for the
delivery of GBP1 to ruptured endosomes generally resembled those for the targeting of
GBP1 to bacteria. In support of this premise, we observed that delivery of GBP1 to
damaged endosomes was dependent on its functional G domain and CaaX box
(Fig. 3A). We further noticed that the CTSD of GBP1 was essential for the delivery of
GBP1 and sufﬁcient to promote the recruitment of chimeric GBP2 protein to damaged
vesicles (Fig. 3B). Deletion of PBM or mutation of the triple-arginine motif led to
substantially reduced colocalization between galectin-3-marked vacuoles and GBP1
(Fig. 3B), indicating a functional role for the triple-arginine motif in the delivery of GBP1
to disrupted vesicles. These observations suggested that the triple-arginine motif of
GBP1 directly or indirectly detects glycans.
S. ﬂexneri mutants lacking O antigen are targeted infrequently by GBP1.
Because GBP1 detects broken vacuoles that are marked by cytosolically exposed
polysaccharides normally conﬁned to the vacuolar lumen, we speculated that bacterial
surface-exposed polysaccharides similarly underlie the recruitment of GBP1 to S. ﬂex-
neri. We thus investigated whether GBP1 either directly or indirectly detects lipopoly-
saccharide (LPS), the main building block of the Gram-negative bacterial envelope.
Because O antigen forms the outward sugar portion of LPS on the surfaces of bacteria,
we tested GBP1 recruitment to the O-antigen-deﬁcient galU and rfaL “rough” S. ﬂexneri
mutants, which enter the host cell cytosol of nonpolarized epithelial cells at compara-
ble frequencies (32). We found that colocalization of ectopically expressed (Fig. 4B) or
endogenous (Fig. 4C) GBP1 with rough S. ﬂexneri mutants was substantially diminished
relative to that of GBP1 targeting wild-type S. ﬂexneri, indicating that O-antigen
recognition plays an important role in GBP1’s recognition of cytosolic Gram-negative
bacteria.
We previously demonstrated that galectin-3 interacts with a subset of murine GBPs
and promotes their recruitment to Legionella- as well as Yersinia-containing vacuoles
(30). Because galectin-3 binds to O antigen as well as the inner core of LPS (33), we
hypothesized that galectin-3 promotes the delivery of GBP1 to the Gram-negative
bacterium S. ﬂexneri. However, we observed that ectopically expressed GBP1 colocal-
ized with S. ﬂexneri with comparable frequencies in wild-type and galectin-3-deﬁcient
mouse embryonic ﬁbroblasts (MEFs) (Fig. 4D). Together, these data suggest that GBP1
detects cytosolic S. ﬂexneri in an O-antigen-dependent but galectin-3-independent
manner.
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GBP1-decorated S. ﬂexneri cells replicate within intracellular bacterial clusters.
Previous work demonstrated the lytic destruction of GBP-bound cytosolic bacteria inmouse
cells (13, 14). To assess whether recruitment of human GBP1 to S. ﬂexneri would similarly
drive bactericidal effects, we used an IPTG (isopropyl--D-thiogalactopyranoside)-inducible
green ﬂuorescent protein (GFP) reporter system as a bacterial viability indicator. In these
experiments, we infected HeLa cells with reporter-positive S. ﬂexneri and then induced
GFP expression with IPTG at 2 hpi and stained cells for endogenous GBP1 and LPS at
4 hpi (Fig. 5A). As expected, inhibition of bacterial translation with chloramphenicol
treatment at 2 hpi blocked detectable GFP expression at 4 hpi (Fig. 5B), thus validating
the reporter system. We then primed HeLa cells with IFN- to induce endogenous GBP1
expression and to assess the effect of GBP1 targeting on bacterial viability. We found
that GBP1-targeted and -untargeted bacteria were GFP positive at comparable frequen-
cies, indicating that GBP1 recruitment to S. ﬂexneri fails to promote bacterial killing at
this time point (Fig. 5B). Instead, we noticed that GBP1-positive bacteria form intracel-
lular clusters. To measure clustering, we developed an automated scoring matrix
(Fig. S2), as described in Materials and Methods. To determine whether GBP1 might be
responsible for this clustering effect, we generated HeLa cells with GBP1 knocked out
(GBP1KO) (Fig. 5C). Following IFN- priming to induce expression of GBPs, we observed
FIG 3 Localization of GBP1 to damaged endosomes is dependent on its triple-arginine motif. HEK 293T
cells stably expressing YFP–galectin-3 (Gal3) were transiently transfected with the indicated expression
constructs and approximately 1 day later treated with calcium phosphate precipitates to induce
endosomal damage leading to YFP-Gal3 puncta formation. (A and B) Combined data from 3 independent
experiments are shown. Per independent experiment, 400 YFP-Gal3 puncta were scored for GBP1
colocalization in mCherry-positive cells. Error bars denote SEM. One-way ANOVA was used to assess
signiﬁcance. **, P  0.01; ***, P  0.001; ****, P  0.0001; n.s., nonsigniﬁcant. (B) Arrows within
representative images point to galectin-3-positive vacuoles.
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reduced bacterial clustering in two independent GBP1KO clonal cell lines compared to
the clustering in the parental HeLa cells (Fig. 5D). Bacterial clustering was restored in
GBP1KO cells by ectopically expressing wild-type GBP1 but not a triple-arginine mutant
(Fig. 5D). Furthermore, we found that GBP1-decorated, clustered bacteria not only
remained viable but continued to divide (Fig. 5E; Movie S2). Thus, our observations
indicate that triple-arginine-dependent delivery of GBP1 to cytosolic S. ﬂexneri pro-
motes bacterial clustering but fails to execute bactericidal or bacteriostatic activities.
GBP1 inhibits actin-based motility in a triple-arginine-motif-dependent man-
ner. GBP1-decorated S. ﬂexneri organisms cluster intracellularly and therefore pheno-
copy S. ﬂexneri ΔicsA mutants (Fig. 6A) that lack the ability to form actin tails and hence
are nonmotile inside the host cell cytosol (34). Thus, we hypothesized that GBP1 blocks
S. ﬂexneri actin tail formation. In support of this hypothesis, we observed a marked
reduction in actin tails associated with GBP1-tagged versus -untagged S. ﬂexneri in 293T
cells expressing mCherry-GBP1 (Fig. 6A). To complement these GBP1 overexpression
studies, we scored actin tail-positive bacteria in wild-type versus GBP1KO HeLa cells. We
found that IFN- priming reduced the number of bacteria with actin tails in wild-type
but not in GBP1KO cells (Fig. 6B). Complementation of GBP1KO cells with wild-type GBP1
but not the triple-arginine mutant (GBP1R584–586A) dramatically reduced the number of
actin tail-positive bacteria to levels observed in IFN--primed wild-type cells (Fig. 6B).
FIG 4 Bacterial targeting of GBP1 is diminished for S. ﬂexneri rough mutants. (A) Arrows indicate sites
of truncation of the LPS structure resulting from the loss-of-function mutations in the bacterial genes
galU and rfa. HEK 293T cells were transfected with mCherry-GBP1 or the mCherry control (B), whereas
HeLa cells were left untransfected (C). Following infection with the wild type or the indicated S. ﬂexneri
mutants at an MOI of 50, colocalization of ectopically expressed GBP1 (B) or endogenous GBP1 (C) was
determined. Combined data from at least 3 independent experiments are shown. Per experiment, 400
bacteria were scored per experimental condition. (D) Primary wild-type (WT) (C57BL/6J) and galectin-3/
MEFs were transiently transfected with expression constructs for mCherry-GBP1 or an mCherry control
and subsequently infected with GFP S. ﬂexneri at an MOI of 50. Cells were ﬁxed at 3 hpi, and the
percentage of GBP1-positive bacteria was determined by microscopy. Graphs represent the mean
percentages of GBP1-positive bacteria from three independent experiments. Error bars represent SEM.
Two-way ANOVA was used to assess statistical signiﬁcance. ***, P  0.001; ****, P  0.0001; n.s.,
nonsigniﬁcant.
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Because actin-based motility is required for bacterial cell-to-cell spread, we measured
the impact of IFN--induced GBP1 expression on bacterial dissemination by performing
bacterial plaque assays. As expected, GBP1-mediated inhibition of actin tail formation
correlated with a GBP1-mediated block in cell-to-cell spread (Fig. 6C). Inhibition of
cell-to-cell spread was restored in GBP1KO cells complemented with the wild type but
not the triple-arginine mutant (GBP1R584–586A) (Fig. 6D), indicating that GBP1 targeting
to bacteria is required for inhibition of bacterial cell-to-cell spread.
FIG 5 GBP1-tagged S. ﬂexneri cells replicate within intracellular bacterial aggregates. (A) IFN--primed and
unprimed HeLa cells were infected at an MOI of 50 with S. ﬂexneri carrying an IPTG-inducible GFP reporter
plasmid. IPTG and, where indicated, also chloramphenicol (Cm) were added to the culture medium at 2 hpi.
At 4 hpi, cells were ﬁxed and stained with anti-LPS (blue) and anti-GBP1 (red). A representative image of
infected, IFN--primed HeLa cells is shown. (B) GFP expression was used as a proxy for bacterial viability.
Combined data from 3 independent experiments as described for panel A are shown. (C) Protein lysates
from IFN--primed parental HeLa (WT) and two independent GBP1KO clones were transferred to membranes
and probed with anti-GBP1 and anti-GAPDH antibodies. (D) Two independent GBP1KO HeLa cell clones were
transfected with wild-type GBP1 or GBP1R584–586A mCherry fusion proteins and then infected with S. ﬂexneri
at an MOI of 50. Bacteria were visualized with anti-LPS (blue) immunostaining. Cluster analysis was
performed as described in Materials and Methods, and the percentage of total bacterial volume occupied
by clusters of greater than three bacteria was determined in mCherry-positive cells using the ImageJ 3D-OC
plugin. The graph depicts the combined data from three independent experiments. Error bars represent
SEM. (E) GBP1KO HeLa cells were transfected with mCherry-GBP1 and infected with poly-D-lysine-pretreated
S. ﬂexneri at an MOI of 10. Cells were infected for 30 min, washed, and then placed in phenol red-free
DMEM. Video microscopy was begun at 2 hpi (2:00 a.m.). Images of 6-min intervals between 2:00 a.m. and
2:42 are shown. Arrowheads point to bacteria that have undergone cell division. Two-way ANOVA was used
to assess statistical signiﬁcance. ****, P  0.0001; n.s., nonsigniﬁcant.
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Endogenous GBP1 associates with S. ﬂexneri and recruits additional GBP
paralogs in HeLa but not in A549 cells. GBP1 frequently forms heterodimers with
other members of the GBP family, such as GBP2 (3–5). To determine whether GBP1
recruits other GBP paralogs to cytosolic S. ﬂexneri, we ectopically expressed mCherry-
tagged human GBP1 to -7 in wild-type and GBP1KO HeLa cells and monitored for
FIG 6 GBP1 restricts actin tail formation and cell-to-cell spread via its triple-arginine motif. (A) HEK 293T
cells were transfected with mCherry-GBP1 and then infected with wild-type (WT) or icsA S. ﬂexneri at an
MOI of 50. Confocal images were taken at 3 hpi and analyzed for actin tail formation as described in
Materials and Methods. Arrows point at actin tails. Data are combined from 3 independent experiments.
Per experiment and condition, 550 bacteria were examined in mCherry-positive cells. (B) Parental
HeLa-Cas9 (WT) and GBP1KO cells were transfected with mCherry-GBP1 or mCherry-GBP1R584–586A as
indicated and then primed with IFN- overnight and infected with S. ﬂexneri at an MOI of 50. Cells were
ﬁxed and stained at 3 hpi, and representative images are shown. Arrows point at actin tails. Bacterial actin
tail formation inside mCherry-positive cells was quantiﬁed, and combined data from 3 independent
experiments are shown. (C) Plaque assays of IFN--primed cells were performed as described in Materials
and Methods, and combined data from 3 independent experiments as well as representative images are
shown. (D) HeLa-Cas9 (WT) cells and the GBP1KO clone (#1) with stably integrated pInducer-GBP1 or
pInducer-GBP1R584–586A expression constructs where either primed with IFN- or stimulated with 1 g/ml
aTc, as indicated. Combined data from 3 independent experiments are shown. Error bars depict SEM (A
to C) or standard deviations (SD) (D). Two-way (A to B) and 1-way (C to D) ANOVAs were used to
determine statistical signiﬁcance. **, P  0.01; ***, P  0.001; ****, P  0.0001; n.s., nonsigniﬁcant.
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subcellular colocalization of each with cytosolic S. ﬂexneri. We found that ectopically
expressed GBP2 and, to a lesser extent, GBP3, GBP4, and GBP6 colocalized with
S. ﬂexneri in HeLa cells in a GBP1-dependent manner (Fig. 7A). This ﬁnding was curious,
as we had not observed any colocalization of these GBP paralogs with S. ﬂexneri in
wild-type A549 cells (Fig. 1A). We therefore monitored the subcellular localization of
endogenous GBP1 in A549 cells and found that endogenous GBP1 targeted S. ﬂexneri
in HeLa but not in A549 cells (Fig. 7B), which correlated with reduced expression of
GBP1 protein in A549 compared to in HeLa cells (Fig. 7C). While endogenous GBP1
failed to decorate S. ﬂexneri in A549 cells, we noticed that in the same cell line, about
40% of cytosolic B. thailandensis bacteria stained positive for endogenous GBP1
(Fig. 7B). These data suggested that B. thailandensis is more susceptible to GBP1
targeting than S. ﬂexneri. To test this hypothesis, we generated a titratable, i.e.,
anhydrotetracycline (aTc)-inducible, expression system for GBP1 (Fig. 7D). As expected,
higher GBP1 expression levels promoted more-frequent colocalization with either
bacterium. However, the overall frequency of GBP1 colocalization was signiﬁcantly
higher for B. thailandensis than for S. ﬂexneri (Fig. 7E). These data indicated that
FIG 7 Endogenous GBP1 colocalizes with S. ﬂexneri and recruits additional GBP paralogs in HeLa but not
in A549 cells. (A) HeLa-Cas9 (WT) and GBP1KO cells were transfected with the indicated mCherry-GBP
expression constructs and primed with IFN- overnight. Cells were infected with GFP S. ﬂexneri at an
MOI of 50 and ﬁxed at 3 hpi, and mCherry-positive cells were analyzed for bacterial colocalization with
GBPs. The combined data from 3 independent experiments are shown. Per experiment and condition,
300 bacteria were scored. Error bars denote SEM, and Student’s t tests were used to determine
statistical signiﬁcance. (B) IFN--primed HeLa and A549 cells were infected with GFP S. ﬂexneri at an MOI
of 50 or with GFP B. thailandensis at an MOI of 100 and ﬁxed and stained with anti-GBP1 at 3 hpi and
8 hpi, respectively. Combined data are from 3 independent experiments (600 bacteria were counted
per experiment) are shown. Error bars represent SEM, and two-way ANOVA was used to assess
signiﬁcance. (C) Expression of endogenous GBP1 in IFN--primed HeLa and A549 cells was assessed by
Western blotting. (D) GBP1KO HeLa cells with stably integrated pInducer-GBP1 were stimulated overnight
with the indicated concentrations of aTc, and protein lysates were subjected to Western blotting. Protein
lysates from IFN--primed A549 and HeLa-Cas9 cells were included for comparison. (E) GBP1KO HeLa cells
with stably integrated pInducer-GBP1 were stimulated overnight with the indicated concentrations of
aTc and then infected with GFP S. ﬂexneri (MOI of 50) for 3 h or GFP B. thailandensis (MOI 100) for 8 h
and analyzed for bacterial colocalization with endogenous GBP1. Combined data from 3 independent
experiments (400 bacteria were counted per experiment) are shown. Error bars represent SEM. *, P 
0.05; **, P  0.01; ***, P  0.001; n.s., nonsigniﬁcant.
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S. ﬂexneri is more resistant to GBP1 targeting than B. thailandensis and therefore
suggested that S. ﬂexneri actively interferes with cytosolic detection by GBP1.
IpaH9.8 blocks GBP1 recruitment and GBP1-mediated inhibition of actin-based
motility. To account for our observations, we hypothesized that an effector secreted by
the Shigella type 3 secretion system (T3SS) interferes with GBP1 targeting to cytosolic
bacteria. To test this hypothesis, we monitored colocalization of GBP1 with two
S. ﬂexneri mutants deﬁcient for the secretion of distinct subsets of type III effectors. A
bacterial mutant lacking Spa15, the chaperone required for the secretion of the
effectors IpaA, IpgB1, IpgB2, OspB, OspC1, OspC2, OspC3, OspD1, and OspD2 (35–38),
was targeted with the same efﬁciency as in wild-type S. ﬂexneri (Fig. 8A). However,
Shigella ΔmxiE, a strain lacking the transcription factor that controls expression of
second-phase S. ﬂexneri effectors, including all IpaH effectors as well as OspB, OspC1,
OspE1, OspE2, OspF, OspG, and VirA (39–41), colocalized more frequently with GBP1
than did wild-type S. ﬂexneri in both A549 and HeLa cells (Fig. 8A). These ﬁndings
indicated that one or more mxiE-dependent T3SS effectors interfered with GBP1
function. To identify this virulence factor, we screened S. ﬂexneri mutants deﬁcient in
individual mxiE-dependent T3SS effectors encoded on the S. ﬂexneri virulence plasmid
and found that the ΔipaH9.8 strain mimicked the ΔmxiE phenotype (Fig. 8B), conﬁrming
similar results published during the preparation of this paper (21, 22). Further, we found
that the ΔipaH9.8 strain was deﬁcient for cell-to-cell spread in parental HeLa but not in
GBP1KO cells (Fig. 8C), indicating that IpaH9.8-mediated interference with GBP1 target-
FIG 8 IpaH9.8 blocks GBP1 recruitment and GBP1-mediated inhibition of actin-based motility. (A)
IFN--primed HeLa and A549 cells were infected with the indicated S. ﬂexneri strains at an MOI of 50 and
at 3 hpi processed and analyzed for colocalization with endogenous GBP1. Data are combined from 3
independent experiments scoring 600 bacteria per experiment. One-way ANOVA was used to determine
signiﬁcance. (B) Experiments were conducted as described for panel A with the S. ﬂexneri mutant strains,
as listed. Two-way ANOVA was used to determine the signiﬁcance of combined data from 3 independent
experiments. (C) IFN--primed HeLa-Cas9 and derived GBP1KO cells were infected with the indicated
S. ﬂexneri mutant strains. Representative images of plaques are shown. Combined data from 3 indepen-
dent experiments are depicted. Error bars indicate SD. Two-way ANOVA was used to determine
signiﬁcance. **, P  0.01; ***, P  0.001; ****, P  0.0001; n.s., nonsigniﬁcant.
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ing is critical for S. ﬂexneri dissemination throughout the colonic epithelium. Cell-
to-cell spread of the ΔmxiE mutant compared to that of wild-type S. ﬂexneri was still
moderately diminished in GBP1KO cells, suggesting that one or more additional mxiE-
controlled effectors other than ipaH9.8 promote cellular dissemination (Fig. 8C).
DISCUSSION
Many cell-autonomous defense mechanisms depend on the ability of the host cell
to detect the precise location of a microbe inside an infected host cell (42). Pathogen-
containing vacuoles are targeted by GBPs following immune recognition through
missing-self or aberrant-self mechanisms (30, 43, 44), but the mechanism by which
GBPs detect cytosolic pathogens had not previously been investigated. Here, we
demonstrate that human GBP1 contains a unique triple-arginine motif within its ﬂexible
C-terminal region, which mediates the delivery of GBP1 to the Gram-negative cytosolic
pathogen S. ﬂexneri. We also demonstrate in this study that rough S. ﬂexneri mutants
lacking LPS O antigen are targeted less efﬁciently by GBP1 than the coisogenic
wild-type strain. These observations suggest that the triple-arginine motif of human
GBP1 either directly or indirectly interacts with the polysaccharide portion of LPS on the
bacterial surface.
GBP1 binding to bacteria still occurs in the absence of O antigen, albeit less
efﬁciently than in its presence. One possible explanation for this observation is that
GBP1 associates with LPS through two or more distinct interactions, as has been
described for galectin-3. Galectin-3 binds to LPS through a high-afﬁnity interaction with
O antigen as well as a low-afﬁnity interaction with the inner LPS core (33). Alternatively,
GBP1 might be recruited to bacteria through an additional LPS-independent mecha-
nism. Future in vitro binding studies are required to test whether GBP1 binds to
Gram-negative bacteria directly or indirectly and to identify the speciﬁc binding
substrate(s) or interaction partner(s) of the C-terminal triple-arginine motif essential for
immune targeting of cytosolic S. ﬂexneri by GBP1.
Previous work demonstrated that deposition of murine GBP2 on the cytosolic
bacterial pathogen Francisella novicida results in bacteriolysis (13, 14). Similarly, murine
GBPs also promote the lytic destruction of S. ﬂexneri (21). Unexpectedly, we found that
the delivery of human GBP1 to cytosolic S. ﬂexneri is insufﬁcient to kill bacteria or halt
their replication. Instead, we observed that GBP1-bound bacteria fail to form actin tails
and are consequentially restricted for efﬁcient cell-to-cell spread. These observations
were conﬁrmed by an independent report published during the preparation of our
manuscript (22). The differences between mouse and human with regard to the
consequences of GBP targeting are intriguing and warrant future investigations to
determine, for instance, whether the lytic pathway present in mouse cells is absent
from human cells. The latter model is supported by a report demonstrating that
GBP-dependent recruitment of the IFN-inducible GTPase Irgb10 to cytosolic F. novicida
is required for bacteriolysis in mouse cells (45). Importantly, genes encoding Irgb10 and
its paralogous subset of immunity-related GTPases (IRGs) with a canonical GXXXXGKS
P-loop sequence are absent from the human genome (46, 47), potentially accounting
for the absence of an intracellular bacteriolytic pathway in human cells.
The dysregulation of cell-autonomous defense programs by S. ﬂexneri is paramount
to the microbe’s ability to colonize its human host and establish an infection (48). In
agreement with two studies published during the preparation of our manuscript (21,
22), we found that the translocated bacterial ubiquitin E3 ligase IpaH9.8 inhibits the
association of GBP1 with cytosolic S. ﬂexneri in human cells. We did not investigate
the mechanism by which IpaH9.8 interferes with GBP1 localization to bacteria, but the
aforementioned studies demonstrated that IpaH9.8 ubiquitinates GBP1 and promotes
its degradation via the proteasome (21, 22). While proteolytic degradation was clearly
demonstrated for infections with a high multiplicity of infection (MOI) or in cells
ectopically expressing IpaH9.8 (21, 22), we failed to observe a pronounced decrease in
GBP1 protein expression in cells infected with S. ﬂexneri under the infection conditions
used in our studies (Fig. 7C). Furthermore, video microscopy data suggest that GBP1
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ubiquitination by IpaH9.8 helps to dislodge GBP1 from targeted bacteria (22). We
therefore propose that ubiquitination by IpaH9.8 not only tags GBP1 for proteolytic
degradation but also directly blocks binding of GBP1 to bacteria and/or removes GBP1
from already-targeted bacteria. Importantly, Li et al. demonstrated that IpaH9.8 pro-
motes polyubiquitination of the GBP1 residues K582 and K587 (21), which ﬂank the
triple-arginine motif essential for recruiting GBP1 to S. ﬂexneri. Whether PBM ubiquiti-
nation blocks GBP1 binding to bacteria through steric hindrance will be investigated in
future studies.
MATERIALS AND METHODS
Cell lines and culture. Primary wild-type and galectin-3KO (49) MEFs were made from C57BL/6J
background mice acquired from The Jackson Laboratory. MEFs, A549, HEK 293T, and HeLa cells
were maintained at 37°C and 5% CO2 in Dulbecco modiﬁed Eagle medium (DMEM) supplemented
with 10% heat-inactivated fetal bovine serum (FBS), nonessential amino acids (Gibco), and 55 M
-mercaptoethanol. GBP1KO lines were derived from HeLa-Cas9 cells, which contain a stably integrated
Cas9 expression vector, lentiCas9-Blast (50). HeLa-Cas9 cells were transiently transfected with two guide
RNAs directed against exon 6, GBP1 to -2 (TTGATCGGCCCGTTCACCGC) and GBP1 to -3 (TCCGGATACA
GAGTCTGGGC), to introduce a predicted 64-bp deletion. Single clones were isolated by dilution.
Resulting alleles are described in Table S1 in the supplemental material. All instances of IFN- priming
were done overnight at 200 U/ml.
Bacterial strains and infections. Bacterial strains are summarized in Table S2. 2457T S. ﬂexneri-
derived mxiE, ospB, ospC1, virA, IpaH1.4, IpaH4.5, IpaH7.8, and IpaH9.8 mutants were con-
structed using the  red recombinase-mediated recombination system (51) with the DNA oligomers
listed in Table S3. GFP S. ﬂexneri stains contain the vector pGFPmut2 (52). The IPTG-inducible GFP vector
pRK2-IPTG-GFP was a gift from Wendy Picking. S. ﬂexneri was grown at 37°C on tryptic soy agar plates
containing 0.01% Congo red, as well as 50 g/ml carbenicillin for pGFPmut2- and PRK2-IPTG-GFP-
containing strains. For infections, 5 ml tryptic soy broth (TSB) was inoculated with a single Congo
red-positive colony and grown overnight at 37°C with shaking. Saturated cultures were diluted 1:50 in
5 ml fresh TSB and incubated for 2.5 to 3 h at 37°C with shaking. Bacteria were diluted in prewarmed cell
culture medium and spun onto cells for 10 min at 700  g. Plates were incubated at 37°C for 30 min and
then washed twice with Hanks balanced salt solution (HBSS), followed by addition of cell culture medium
containing 25 g/ml gentamicin and further incubation at 37°C. Unless otherwise speciﬁed, cells were
infected at an MOI of 50. For time-lapse microscopy and plaque assays, 5  107 bacteria were harvested
by centrifugation and incubated in 1 ml phosphate-buffered saline (PBS) containing 5 g/ml poly-D-
lysine at 37°C for 15 min with shaking, as described previously (53). Poly-D-lysine-pretreated bacteria
were then used for infection, as described above. The B. thailandensis wild-type strain E264 carrying a
GFP expression construct was a gift from Edward Miao. B. thailandensis plus GFP was grown at 37°C on
LB plates containing 100 g/ml trimethoprim. For infections, overnight cultures were diluted 1:20 in LB
plus trimethoprim and grown for 3 h at 37°C with shaking. Cells were infected at an MOI of 100, as
described above. Infected plates were incubated at 37°C for 2.5 h, washed twice with HBSS, and
incubated in the presence of 30 g/ml kanamycin for 2 h. Kanamycin-containing medium was then
replaced with medium without antibiotics, and the plates were incubated at 37°C to 8 hpi. GFP
wild-type L. monocytogenes strain 10403S was previously described (54); it was grown at 37°C on brain
heart infusion (BHI) plates containing 10 g/ml streptomycin and 7.5 g/ml chloramphenicol. Infections
were carried out in a manner identical to that used for S. ﬂexneri by using saturated overnight cultures
grown at 37°C with shaking. Cells were infected with L. monocytogenes at an MOI of 5.
Design of GBP expression constructs. Vectors containing mCherry-tagged constructs are deriva-
tives of pmCherry-C1 (Clontech) and were constructed using the DNA oligomers and restriction endo-
nucleases listed in Table S4. For the chimeric constructs GBP1/2CTSD and GBP2/1CTSD, two synonymous
mutations were introduced into GBP1 codons 478 and 479 of pmCherry-GBP1 using QuikChange
site-directed mutagenesis with GBP1-BclI oligomers (Table S5). These mutations introduced a BclI
restriction endonuclease site within the sequence encoding the ﬂexible region between helices 11 and
12. Following propagation of pmCherry-GBP1BclI and pmCherry-GBP2 in dam- and dcm-negative E. coli
cells (New England Biolabs), BclI digestion and T4 ligase-dependent repair were used to exchange the
fragment encoding the C-terminal regions of the two proteins. All other mCherry-tagged chimeric and
mutant constructs were constructed using QuikChange site-directed mutagenesis with the primers listed
in Table S5. GBP2PBMGBP1-CaaX was constructed stepwise from pmCherry-GBP2PBM mutated with
GBP2/1CaaX and then GBP2I587A oligomers. Tetracycline-inducible GBP1 was constructed by inserting the
GBP1 open reading frame into the third-generation Tet-on vector pInducer20 (55), using Gateway Cloning
Technology with the GBP1-attB oligomers listed in Table S5. GBP1R584–586A was constructed by mutating the
entry vector pDONR221-GBP1 via QuikChange site-directed mutagenesis using GBP1R584–586A oligomers prior
to Gateway LR reactions.
Immunoﬂuorescence microscopy, actin tail analysis, time-lapse microscopy, and CPP assays.
For standard microscopy, cells were ﬁxed in 4% paraformaldehyde and permeabilized with 0.25% Triton
X-100 in PBS. Coverslips were probed with a 1:150 dilution of a rabbit monoclonal antibody against
human GBP1 (Abcam, Inc.; ab131255) and/or a 1:50 dilution of a mouse monoclonal antibody against LPS
(RayBiotech; DS-MB-01267) and then with Alexa Fluor-conjugated secondary antibodies and 4 g/ml of
the nuclear dye Hoechst, where appropriate. For actin tail analysis, 1:40 phalloidin conjugated to Alex
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Fluor 488 was added to the secondary antibody mix. For each ﬁeld of view, Z-stacks were taken at 0.5-m
intervals on a Zeiss 710 inverted confocal microscope to encompass the thickness of the cells. The
percentage of bacteria with tails was determined by referencing across the collected Z-stacks through a
blind analysis. For time-lapse microscopy, GBP1KO HeLa cells were plated in 35-mm glass-bottom plates
(MatTek) and transfected with pmCherry-GBP1. Cells were infected with GFP S. ﬂexneri pretreated with
poly-D-lysine at an MOI of 10. Cells were imaged in DMEM without phenol red but with 5% FBS and
25 g/ml gentamicin. Calcium phosphate precipitate (CPP) assays were carried out in HEK 293T cells
stably expressing yellow ﬂuorescent protein (YFP)–galectin-3 and transiently transfected with mCherry-
tagged GBP constructs, as described in reference 30. CPP assays were carried out in HEK 293T cells stably
expressing YFP–galectin-3 and transiently transfected with mCherry-tagged GBP constructs, as described
in reference 30.
IPTG-inducible GFP viability assay. HeLa cells were stimulated overnight with 200 U/ml IFN- and
infected with S. ﬂexneri containing the IPTG-inducible GFP vector pRK2-IPTG-GFP. At 2 hpi, IPTG was
added to a concentration of 1 mM. Chloramphenicol was also added to a concentration of 60 g/ml for
negative controls. Coverslips were incubated for an additional 2 h before being ﬁxed and stained with
anti-LPS and anti-GBP1 antibodies, as described above.
S. ﬂexneri cluster analysis. Three-color Z-stack images were acquired on a Zeiss 710 inverted
confocal microscope. For cluster analysis, these images were separated into individual color Z-stacks.
Z-stacks not containing bacterial signal were discarded. The image was then examined for the threshold
to remove background signals, and the three-dimensional object counter (3D-OC) plugin (ImageJ) (56)
was used to identify connected objects. To exclude nonspeciﬁc signals, an object was deﬁned as a
minimum of 10 connected voxels above a set signal threshold and each object was assigned a unique
tag. The average size of an individual bacterium was approximated to be 50 voxels. Objects with a
volume of greater than 150 voxels (3 or more bacteria) were deﬁned as a cluster.
Plaque assays. Plaque assays were performed essentially as previously described (57). Cells were
plated to conﬂuence in 35-mm glass-bottom plates and stimulated overnight with 200 U/ml IFN-. Cells
were infected at an MOI of 5 104 with GFP S. ﬂexneri pretreated with poly-D-lysine. Following 30 min
of infection at 37°C, plates were washed twice with HBSS and overlaid with 1.5 ml DMEM without phenol
red supplement but with 5% FBS containing 25 g/ml gentamicin, 200 U/ml IFN-, 50 g/ml carbeni-
cillin, and 0.5% agarose. Plates were incubated for 10 min at room temperature before addition of 1 ml
of cell culture medium without agarose. Plaques were visualized using phase-contrast and ﬂuorescence
microscopy at 24 hpi, and Feret’s diameter of individual bacterial plaques was determined using FIJI
software. For plaque assays using GBP1KO cells complemented with pInducer-GBP1 or -GBP1R584586, cells
were stimulated overnight with 1 g/ml aTc.
Titration of GBP1 expression from a Tet-inducible expression system and immunoblots. GBP1KO
cells stably transduced with pInducer-GBP1 constructs were incubated overnight with cell culture
medium containing the concentrations of aTc indicated in Fig. 6 and 7. Cells were lysed in radioimmu-
noprecipitation assay (RIPA) buffer containing 1 protease inhibitor cocktail (Sigma) for 5 min on ice.
Lysates were spun for 10 min at maximum speed in a microcentrifuge at 4°C and then combined with
an equivalent volume of 2 Laemmli sample buffer containing -mercaptoethanol and incubated at
95°C for 10 min. Samples were run on 4 to 15% Mini-Protean TGX gels (Bio-Rad) and transferred to
nitrocellulose. Immunoblots were probed with 1:1,000 anti-GBP1 (Abcam, Inc.; ab131255), 1:1,000
anti-mCherry rabbit polyclonal (Abcam, Inc.; ab183628), or anti-GAPDH (glyceraldehyde-3-phosphate
dehydrogenase) rabbit polyclonal (Abcam, Inc.; ab9485) antibody, followed by horseradish peroxidase-
conjugated anti-rabbit IgG (Invitrogen).
Statistical analyses Data analysis was performed using GraphPad Prism 6.0 software. Data shown are
means  standard errors of the means (SEM) unless otherwise indicated. Statistical signiﬁcance was
calculated using one-way or two-way analysis of variance (ANOVA) or Student’s t test, as indicated.
Signiﬁcance was deﬁned as follows: ****, P  0.0001; ***, P  0.001; **, P  0.01; and *, P  0.05.
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